Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Neurology ; 71(18): 1402-9, 2008 Oct 28.
Article in English | MEDLINE | ID: mdl-18799783

ABSTRACT

OBJECTIVE: Mutations in the gene encoding phospholipase A(2) group VI (PLA2G6) are associated with two childhood neurologic disorders: infantile neuroaxonal dystrophy (INAD) and idiopathic neurodegeneration with brain iron accumulation (NBIA). INAD is a severe progressive psychomotor disorder in which axonal spheroids are found in brain, spinal cord, and peripheral nerves. High globus pallidus iron is an inconsistent feature of INAD; however, it is a diagnostic criterion of NBIA, which describes a clinically and genetically heterogeneous group of disorders that share this hallmark feature. We sought to delineate the clinical, radiographic, pathologic, and genetic features of disease resulting from defective phospholipase A(2). METHODS: We identified 56 patients clinically diagnosed with INAD and 23 with idiopathic NBIA and screened their DNA for PLA2G6 mutations. RESULTS: Eighty percent of patients with INAD had mutations in PLA2G6, whereas mutations were found in only 20% of those with idiopathic NBIA. All patients with two null mutations had a more severe phenotype. On MRI, nearly all mutation-positive patients had cerebellar atrophy, and half showed brain iron accumulation. We observed Lewy bodies and neurofibrillary tangles in association with PLA2G6 mutations. CONCLUSION: Defects in phospholipase A(2) lead to a range of phenotypes. PLA2G6 mutations are associated with nearly all cases of classic infantile neuroaxonal dystrophy but a minority of cases of idiopathic neurodegeneration with brain iron accumulation, and genotype correlates with phenotype. Cerebellar atrophy predicts which patients are likely to be mutation-positive. The neuropathologic changes that are caused by defective phospholipase A(2) suggest a shared pathogenesis with both Parkinson and Alzheimer diseases.


Subject(s)
Brain/metabolism , Genetic Predisposition to Disease , Group VI Phospholipases A2/genetics , Iron/metabolism , Mutation , Neurodegenerative Diseases/genetics , Neurodegenerative Diseases/pathology , Adolescent , Child , Child, Preschool , DNA Mutational Analysis , Family Health , Female , Humans , Magnetic Resonance Imaging/methods , Male , Neurodegenerative Diseases/diagnostic imaging , Radionuclide Imaging
2.
Neuroscience ; 112(1): 1-5, 2002.
Article in English | MEDLINE | ID: mdl-12044466

ABSTRACT

Gene transfer into CNS is critical for potential therapeutic applications as well as for the study of the genetic basis of neural development and nerve function. Unfortunately, lipid-based gene transfer to CNS cells is extremely inefficient since the nucleus of these post-mitotic cells presents a significant barrier to transfection. We report the development of a simple and highly efficient lipofection method for primary embryonic rat hippocampal neurons (up to 25% transfection) that exploits the M9 sequence of the non-classical nuclear localization signal of heterogeneous nuclear ribonucleoprotein A1 for targeting beta(2)-karyopherin (transportin-1). M9-assistant lipofection resulted in 20-100-fold enhancement of transfection over lipofection alone for embryonic-derived retinal ganglion cells, rat pheochromocytoma (PC12) cells, embryonic rat ventral mesencephalon neurons, as well as the clinically relevant human NT2 cells or retinoic acid-differentiated NT2 neurons. This technique can facilitate the implementation of promoter construct experiments in post-mitotic cells, stable transformant generation, and dominant-negative mutant expression techniques in CNS cells.


Subject(s)
Cell Nucleus/metabolism , Neurons/metabolism , Protein Sorting Signals/physiology , Transfection/methods , Animals , Cell Line , Chick Embryo , Culture Techniques , Embryo, Mammalian , Hippocampus/metabolism , Humans , Liposomes , Rats , Rats, Sprague-Dawley , Tissue Distribution
3.
J Mol Neurosci ; 17(2): 225-32, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11816795

ABSTRACT

Lewy bodies, the characteristic pathological lesion of substantia nigra neurons in Parkinson's disease (PD), are frequently observed to accompany the amyloid plaque and neurofibrillary tangle pathology of Alzheimer's disease (AD). However the typical anatomic distribution of Lewy bodies in AD is distinct from PD. The most common site of occurrence is the amygdala, where Lewy bodies are observed in approximately 60% of both sporadic and familial AD. Other common sites of occurrence include the periamygdaloid and entorhinal cortex, while neocortical and brainstem areas develop Lewy bodies in a lower percentage of cases. In contrast, dementia with Lewy bodies (DLB), defined by widespread neocortical and brainstem Lewy bodies but frequently accompanied by variable levels of AD-type pathology, represents the other end of a spectrum of pathology associated with dementia. The observation of Lewy bodies in familial AD cases suggests that like neurofibrillary tangles, the formation of Lewy bodies can be induced by the pathological state caused by Abeta-amyloid overproduction. The role of Lewy body formation in the dysfunction and degeneration of neurons remains unclear. The protein alpha-synuclein appears to be an important structural component of Lewy bodies, an observation spurred by the discovery of point mutations in the alpha-synuclein gene linked to rare cases of autosomal dominant PD. Further investigation of alpha-synuclein and its relationship to pathological conditions promoting Lewy body formation in AD, PD, and DLB may yield further insight into pathogenesis of these diseases.


Subject(s)
Alzheimer Disease/pathology , Brain/pathology , Lewy Bodies/pathology , Neurons/pathology , Alzheimer Disease/genetics , Amyloid beta-Peptides/metabolism , Animals , Humans , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Oxidative Stress/physiology , Point Mutation/physiology , Synucleins , alpha-Synuclein , tau Proteins/metabolism
4.
J Comp Neurol ; 398(1): 139-50, 1998 Aug 17.
Article in English | MEDLINE | ID: mdl-9703032

ABSTRACT

Neurturin (NTN) and glial cell line-derived neurotrophic factor (GDNF) are the first two members of the GDNF family (GF) of neurotrophic factors. These two proteins are potent survival factors for several populations of central and peripheral neurons in mature and developing rodents. The receptor for these factors is a multicomponent complex that includes the RET (rearranged during transfection) tyrosine kinase receptor and one of two glycosyl phosphatidylinositol (GPI)-linked ligand-binding components called GDNF family receptor alphas (GFRalpha-1 and GFRalpha-2). We have used in situ hybridization to study the mRNA expression of NTN, GDNF, RET, GFRalpha-1, and GFRalpha-2 in the central nervous system (CNS) of adult mice. GF receptors are expressed in several areas in which neuronal populations known to respond to NTN and GDNF are located, including the ventral horn of the spinal cord and the compacta region of the substantia nigra. In addition, we have demonstrated receptor expression in other areas of the brain including the thalamus and hypothalamus. Neurons in these areas express GF receptors, and therefore, may respond to NTN or GDNF. NTN and GDNF are expressed in targets of neurons that express GF receptors. The pattern of GF factor and receptor expression in the adult brain suggests a role for these factors in maintaining neuronal circuits in the mature CNS.


Subject(s)
Drosophila Proteins , Mice, Inbred ICR/physiology , Nerve Growth Factors/genetics , Nerve Tissue Proteins/genetics , Neuroprotective Agents/metabolism , Proto-Oncogene Proteins/genetics , Receptor Protein-Tyrosine Kinases/genetics , Age Factors , Animals , Brain Chemistry/physiology , Brain Stem/chemistry , Brain Stem/cytology , Cerebellum/chemistry , Cerebellum/cytology , Female , Gene Expression/physiology , Glial Cell Line-Derived Neurotrophic Factor , Glial Cell Line-Derived Neurotrophic Factor Receptors , Hypothalamus/chemistry , Hypothalamus/cytology , In Situ Hybridization , Mesencephalon/chemistry , Mesencephalon/cytology , Mice , Neurturin , Olfactory Bulb/chemistry , Olfactory Bulb/cytology , Prosencephalon/chemistry , Prosencephalon/cytology , Proto-Oncogene Proteins c-ret , RNA, Messenger/analysis , Spinal Cord/chemistry , Spinal Cord/cytology , Thalamus/chemistry , Thalamus/cytology
5.
Neuron ; 20(2): 245-53, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9491986

ABSTRACT

A novel neurotrophic factor named Persephin that is approximately 40% identical to glial cell line-derived neurotrophic factor (GDNF) and neurturin (NTN) has been identified using degenerate PCR. Persephin, like GDNF and NTN, promotes the survival of ventral midbrain dopaminergic neurons in culture and prevents their degeneration after 6-hydroxydopamine treatment in vivo. Persephin also supports the survival of motor neurons in culture and in vivo after sciatic nerve axotomy and, like GDNF, promotes ureteric bud branching. However, in contrast to GDNF and NTN, persephin does not support any of the peripheral neurons that were examined. Fibroblasts transfected with Ret and one of the coreceptors GFRalpha-1 or GFRalpha-2 do not respond to persephin, suggesting that persephin utilizes additional, or different, receptor components than GDNF and NTN.


Subject(s)
Motor Neurons/chemistry , Nerve Growth Factors/genetics , Nerve Tissue Proteins/genetics , Neuroprotective Agents/metabolism , Animals , Cell Death/physiology , Cell Survival/drug effects , Cells, Cultured , Ganglia, Spinal/cytology , Gene Expression Regulation, Developmental , Glial Cell Line-Derived Neurotrophic Factor , Humans , Mesencephalon/cytology , Mice , Molecular Sequence Data , Motor Neurons/physiology , Neurturin , Nodose Ganglion/cytology , Polymerase Chain Reaction/methods , Rats , Rats, Sprague-Dawley , Receptors, Growth Factor/physiology , Receptors, Retinoic Acid/physiology , Sequence Homology, Amino Acid , Signal Transduction/physiology , Superior Cervical Ganglion/cytology , Transfection , Trigeminal Ganglion/cytology , Ureter/cytology , Ureter/embryology
6.
J Biol Chem ; 273(6): 3654-60, 1998 Feb 06.
Article in English | MEDLINE | ID: mdl-9452495

ABSTRACT

The G401 cell line derived from a rhabdoid tumor of the kidney secretes the heparin-binding growth factors midkine and pleiotrophin. Both proteins act as mitogens for diverse cells, but only midkine serves as an autocrine mitogen for G401 tumor cells. We show that midkine specifically binds a protein or complex of molecular mass greater than 200 kDa with high affinity (Kd = 0.07 +/- 0.01 nM). Midkine, but not pleiotrophin, stimulates tyrosine phosphorylation of several cellular proteins with molecular mass of 100, 130, and 200+ kDa. Upon midkine binding, the midkine-receptor complex associates with the Janus tyrosine kinases, JAK1 and JAK2. MK stimulates tyrosine phosphorylation of JAK1, JAK2, and STAT1alpha. Our initial characterization of the midkine receptor suggests that midkine autocrine stimulation of tumor cell proliferation is mediated by a cell-surface receptor which in turn might activate the JAK/STAT pathway.


Subject(s)
Carrier Proteins/pharmacology , Cell Division/drug effects , Cytokines , Protein-Tyrosine Kinases/metabolism , Proto-Oncogene Proteins , Receptor Protein-Tyrosine Kinases/metabolism , Signal Transduction , Animals , Cell Line , Enzyme Activation , Humans , Janus Kinase 1 , Janus Kinase 2 , Midkine , Receptors, Cell Surface/metabolism , Tumor Cells, Cultured
7.
Nature ; 384(6608): 467-70, 1996 Dec 05.
Article in English | MEDLINE | ID: mdl-8945474

ABSTRACT

The normal development of the vertebrate nervous system entails the death of 30-70% of the neurons originally generated in most neuronal populations. This naturally occurring cell death is regulated by specific neurotrophic factors that promote neuronal survival and which are produced in limiting quantities by target cells, glial cells and neurons. These factors are also of potential utility as therapeutic agents for neurodegenerative diseases. Here we describe the purification and cloning of a new neurotrophic factor, identified on the basis of its ability to support the survival of sympathetic neurons in culture. This factor, neurturin, is structurally related to glial-cell-line-derived neurotrophic factor (GDNF). These factors can each activate the MAP kinase signalling pathway in cultured sympathetic neurons and support the survival of sympathetic neurons, as well as of sensory neurons of the nodose and dorsal root ganglia. Thus, neurturin and GDNF together now define a new family of neurotrophic factors.


Subject(s)
Mitogen-Activated Protein Kinases , Nerve Growth Factors/isolation & purification , Nerve Tissue Proteins/chemistry , 3T3 Cells , Amino Acid Sequence , Animals , CHO Cells , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cell Survival/physiology , Cells, Cultured , Chromatography, Affinity , Cloning, Molecular , Cricetinae , Culture Media, Conditioned , DNA, Complementary , Enzyme Activation , Ganglia, Spinal/cytology , Glial Cell Line-Derived Neurotrophic Factor , Humans , Mice , Mitogen-Activated Protein Kinase 1 , Mitogen-Activated Protein Kinase 3 , Molecular Sequence Data , Nerve Growth Factors/chemistry , Nerve Growth Factors/genetics , Nerve Growth Factors/physiology , Neuroglia/physiology , Neurons/physiology , Neurturin , Nodose Ganglion/cytology , Rats , Rats, Sprague-Dawley , Sequence Homology, Amino Acid , Superior Cervical Ganglion/cytology
8.
Brain Res ; 678(1-2): 99-109, 1995 Apr 24.
Article in English | MEDLINE | ID: mdl-7620904

ABSTRACT

Cell-surface carbohydrate epitopes are important determinants in cell-cell and cell-matrix interactions, and oligosaccharide groups are structural components of many growth factor receptors and cell adhesion molecules. These epitopes may participate in the regulation of stem cell proliferation and differentiation during central nervous system development. To further understand these cellular phenomena, it is important to define the changes in neuroepithelial cell-surface carbohydrate expression during development. We used a panel of fluorescein-conjugated lectins to label live, freshly dissociated cells from the embryonic day 11 to 18 (E11 to E18) mouse telencephalon. The intensity and heterogeneity of lectin labeling was assessed by flow cytometry. The lectins that we examined exhibited widely varying levels of labeling intensity. Lectins with the highest degree of binding included cholera toxin B subunit (CTB), which binds primarily to the gangliosides GM1 and GD1b, phaseolus vulgaris erythroagglutinating lectin (PHA-E), which binds to a variety of cell adhesion molecules, and wheat germ agglutinin (WGA). Many lectins showed increasing labeling intensity and cellular heterogeneity as development progressed. To determine if the observed cellular heterogeneity in lectin binding reflected biological differences in neuroepithelial cell subpopulations, cells from the E14 telencephalon were separated into two populations based on their intensity of CTB labeling using a fluorescence activated cell sorter. The population of weakly CTB labeled cells contained more than four times as many cells in S-phase of the cell cycle than the population of intensely CTB labeled cells. These observations suggest that lectin cytochemistry and flow cytometry can be useful in identifying specific cell subpopulations of neuroepithelial precursor cells during development, allowing their isolation and characterization in vitro.


Subject(s)
Lectins/metabolism , Stem Cells/metabolism , Telencephalon/embryology , Animals , Binding, Competitive , Cell Adhesion , Cell Separation , Epithelium/metabolism , Female , Flow Cytometry , Mice , Neurons/metabolism , Oligosaccharides/metabolism , Telencephalon/cytology , Telencephalon/metabolism
9.
Neuron ; 12(4): 763-73, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8161448

ABSTRACT

Embryonic rat sympathetic neurons undergo programmed cell death upon NGF deprivation. We show that during postnatal development, these neurons acquire the ability to be supported in vitro by LIF and CNTF as well as NGF. LIF and CNTF do not promote the long-term survival of embryonic day 21 sympathetic neurons in vitro. However, after 5 days of culture in the presence of NGF, the majority of embryonic day 21 sympathetic neurons can be supported by either of these factors. Furthermore, postnatal day 6 sympathetic neurons can be immediately supported by LIF and CNTF, indicating that acquisition of survival responsiveness occurs in vivo as well as in vitro. During this period, neuronal expression of LIF and CNTF receptor mRNAs remains constant, suggesting that sympathetic neurons alter their responsiveness to LIF and CNTF by allowing additional intracellular signaling pathways to promote survival.


Subject(s)
Growth Inhibitors/pharmacology , Interleukin-6 , Lymphokines/pharmacology , Nerve Tissue Proteins/pharmacology , Neurons/cytology , Sympathetic Nervous System/cytology , Animals , Cell Death , Cell Survival , Cells, Cultured , Ciliary Neurotrophic Factor , Gene Expression , Growth Inhibitors/genetics , Leukemia Inhibitory Factor , Lymphokines/genetics , Nerve Tissue Proteins/genetics , Polymerase Chain Reaction , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Sympathetic Nervous System/embryology , Sympathetic Nervous System/growth & development
10.
Development ; 113(4): 1181-91, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1811935

ABSTRACT

Acetylcholine receptors (AChRs) are highly concentrated in the postsynaptic membrane at the neuromuscular junction. To investigate mechanisms that lead to the formation or maintenance of this synaptic specialization, we generated transgenic mice in which regulatory elements from the AChR alpha or epsilon-subunit genes are linked to a gene for a reporter protein that is targeted to the nucleus (nlacZ). Both transgenes were selectively expressed and developmentally regulated in muscle; nuclei in both extrafusal (ordinary) and intrafusal (spindle) muscle fibers were labeled. Within individual muscle fibers from epsilon-nlacZ mice, nuclei near synaptic sites were nlacZ-positive, whereas extrasynaptic nuclei were nlacZ-negative. In contrast, nlacZ was expressed in both synaptic and extrasynaptic nuclei when under the control of regulatory elements from the AChR alpha-subunit gene; however, synaptic nuclei were somewhat more intensely stained than extrasynaptic nuclei in a minority of muscle fibers from these mice. Together, our results provide direct evidence for molecular differences between synaptic and extrasynaptic nuclei within a single cytoplasm, and suggest that the motor nerve regulates synapse formation by selectively affecting transcription in synaptic nuclei.


Subject(s)
Gene Expression Regulation/physiology , Lac Operon/genetics , Mice, Transgenic/genetics , Muscles/physiology , Neuromuscular Junction/physiology , Receptors, Cholinergic/genetics , Animals , Base Sequence , Embryonic and Fetal Development/genetics , Histological Techniques , Mice , Microscopy, Electron , Molecular Sequence Data , Muscles/ultrastructure , Neuromuscular Junction/ultrastructure , Transcription, Genetic
11.
Proc Natl Acad Sci U S A ; 87(10): 3748-52, 1990 May.
Article in English | MEDLINE | ID: mdl-2339118

ABSTRACT

The transcription of heat shock genes in response to physiological stress requires activation of heat shock transcription factor (HSF). Although the transcriptional response is most commonly induced by temperature elevation, the biochemical events involved in HSF activation in vivo can also be triggered at normal physiological temperatures by chemicals that inhibit metabolic processes. We have used a HeLa cell-free system in which HSF DNA-binding is activated by conditions that affect protein conformation, including increasing concentrations of hydrogen ions, urea, or nonionic detergents. Treatment with calcium ions also results in a concentration- and time-dependent activation of HSF in vitro. Pretreatment with each of these biochemical conditions reduces the temperature dependence for HSF activation in vitro. These results suggest that HSF is activated either directly by undergoing a conformational change or indirectly through interactions with unfolded proteins.


Subject(s)
Calcium/pharmacology , Heat-Shock Proteins/metabolism , Transcription Factors/metabolism , Base Sequence , Binding, Competitive , DNA, Neoplasm/metabolism , Detergents/pharmacology , HeLa Cells/drug effects , HeLa Cells/metabolism , Hot Temperature , Hydrogen-Ion Concentration , Kinetics , Molecular Sequence Data , Protein Binding , Protein Conformation , Urea/pharmacology
12.
Mol Cell Biol ; 9(8): 3166-73, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2796986

ABSTRACT

Hemin-induced differentiation of the human erythroleukemia cell line K562 results in the expression and accumulation of erythroid-specific gene products such as embryonic and fetal hemoglobins and the elevated synthesis of the major heat shock protein HSP70. This activity was suggested to represent activation of a heat shock gene during erythroid maturation independent of stress induction. In this study, we demonstrate that hemin induces the transcription of two members of the human HSP70 gene family, HSP70 and GRP78 (BiP). However, the induction of HSP70 by hemin showed characteristics consistent with the molecular events associated with a heat shock or stress response. The increase in HSP70 gene transcription was accompanied by induction of the stress-induced form of the heat shock transcription factor. Moreover, a heat shock element was required for the hemin responsiveness of chimeric heat shock promoter-chloramphenicol acetyltransferase genes transiently expressed in transfected K562 cells.


Subject(s)
Carrier Proteins/genetics , Cell Differentiation , Gene Expression Regulation , Heat-Shock Proteins/genetics , Heme/analogs & derivatives , Hemin/physiology , Molecular Chaperones , Chloramphenicol O-Acetyltransferase/genetics , DNA, Recombinant , DNA-Binding Proteins/analysis , Endoplasmic Reticulum Chaperone BiP , Genes, Regulator , Humans , Leukemia, Erythroblastic, Acute , Transcription Factors/analysis , Transfection , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...